Today, the Global Grand Challenges (GC) network, a family of global partners fostering innovation to solve key global health and development problems, is announcing a group of 59 grant recipients who are developing ground-breaking solutions to address the impacts of climate change on health, agriculture, and gender equality in Africa, Asia, and the Americas.
Category Archives: Uncategorized
-
Sen. Schumer gives nod to Upstate’s vector-borne disease research in pushing for greater remedies to disease-carrying mosquitoes
U.S. Sen. Chuck Schumer, using the site of Upstate’sVector Biocontainment Laboratoryat the Institute of Human Performance on Tuesday, said pushed to surge funding for the CDC’s Vector-Borne Diseases programs, which includes EEEV and West Nile, with $65 million in new funding to stem the threat to communities from mosquito populations that spread disease.
-
Dosing initiated in Phase 2a trial
We are pleased to share that all subjects in the prophylactic arm of the Phase 2a/b PROTECT clinical trial have received their initial dose of ISLA-101. They will be administered an attenuated strain of dengue fever on 4 October 2024, and we are just weeks away from understanding the potential impact of our drug ISLA-101…
-
Island secures $3.5m in funding
Island has received firm commitments for a two-tranche Placement of A$3.5m at A$0.07 per new share, with one new option attached with every new share issued.
-
Upstate seeks participants for study on new Lyme test
Upstate Medical University is looking for participants for a research study on a new blood test that may detect Lyme disease sooner.